Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cell membrane lipid rafts are small (10–200 nm), heterogeneous, cholesterol- and sphingolipid-enriched microdomains in the plasma membrane that serve as organizing centers for signaling, adhesion, and trafficking proteins in tumor cells[3][5][6]. They facilitate compartmentalization of receptors and signaling molecules, modulate processes such as migration, apoptosis, and drug resistance, and are often more abundant or altered in cancer cells compared to normal cells[1][3][5][6]. Disruption or targeting of lipid raft integrity can interfere with multiple pathways involved in tumor progression and is an active area of therapeutic research[1][2][6][8].
Disruption of raft integrity by depleting cholesterol leads to impaired receptor signaling and promotes apoptosis (e.g., with statins, methyl-β-cyclodextrin); Promoting clustering or recruitment of death receptors in rafts facilitates apoptotic signaling (e.g., with perifosine, edelfosine); Modulation of raft-associated signaling pathways (e.g., PI3K/AKT, IGF, Fas/CD95, Wnt/β-catenin)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell membrane lipid raft (null).